Trials / Sponsors / NexImmune Inc.
NexImmune Inc.
Industry · 3 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Autologous T Cells Targeting HPV16 HPV18 & Survivin in Patients With R/R HPV-related Oropharyngeal Cancers Oropharyngeal Cancer, Human Papilloma Virus, Head and Neck Cancer | Phase 1 | 2025-03-31 |
| Suspended | Antigen-specific T Cell Therapy for Patients With Relapsed Refractory Multiple Myeloma Relapsed Refractory Multiple Myeloma | Phase 1 / Phase 2 | 2020-08-17 |
| Unknown | Antigen-specific T Cell Therapy for AML or MDS Patients With Relapsed Disease After Allo-HCT Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) | Phase 1 / Phase 2 | 2020-02-20 |